FI90420B - Förfarande för framställning av terapeutiskt användbara tetrahydroisokinolinderivat - Google Patents

Förfarande för framställning av terapeutiskt användbara tetrahydroisokinolinderivat Download PDF

Info

Publication number
FI90420B
FI90420B FI883760A FI883760A FI90420B FI 90420 B FI90420 B FI 90420B FI 883760 A FI883760 A FI 883760A FI 883760 A FI883760 A FI 883760A FI 90420 B FI90420 B FI 90420B
Authority
FI
Finland
Prior art keywords
methoxy
preparation
formula
hydroxy
methylene chloride
Prior art date
Application number
FI883760A
Other languages
English (en)
Finnish (fi)
Other versions
FI883760A0 (sv
FI90420C (sv
FI883760A (sv
Inventor
Nigel John Cussans
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of FI883760A0 publication Critical patent/FI883760A0/sv
Publication of FI883760A publication Critical patent/FI883760A/sv
Publication of FI90420B publication Critical patent/FI90420B/sv
Application granted granted Critical
Publication of FI90420C publication Critical patent/FI90420C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)

Claims (5)

1. Förfarande för framställning av terapeutiskt användbara tetrahydroisokinolinderivat med formeln I
10 I ”»2 eller för framställning av ett farmaceutiskt godtagbart sait därav, väri den ena av grupperna R1 och R2 är metoxi 15 och den andra är hydroxi, kännetecknat därav, att förfarandet omfattar följande steg: (a) man cyklise-rar en förening med formeln (II) “’Vv^QCC, ui1 : ΛΛ i - · CH^O CN CH3 25 väri den ena av grupperna R3 och R4 är metoxi och den andra antingen hydroxi eller en skyddad hydroxigrupp, och (b) om sä erfordras avlägsnas skyddsgruppen frän nämnda skyddade hydroxigrupp.
2. Förfarande enligt patentkrav 1, k ä n n e - 30 tecknat därav, att nämnda skyddade hydroxigrupp är en bensyloxigrupp och skyddsgruppen avlägsnas genom kata-lytisk hydrering.
3. Förfarande enligt patentkrav 1 eller 2, kännetecknat därav, att föreningen med formeln (II) 35 cykliseras genom behandling med en Lewis-syra. 17 90 420
4. Förfarande enligt patentkrav 3, k ä n n e -t e c k n a t därav, att produkten som erhälles genom behandling med en Lewis-syra behandlas med en bas.
5. Förfarande enligt patentkrav 3 eller 4, k ä n -5 netecknat därav, att Lewis-syran utgörs av zink- klorid.
FI883760A 1987-08-15 1988-08-12 Förfarande för framställning av terapeutiskt användbara tetrahydroisokinolinderivat FI90420C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878719378A GB8719378D0 (en) 1987-08-15 1987-08-15 Antiarrythmic agents
GB8719378 1987-08-15

Publications (4)

Publication Number Publication Date
FI883760A0 FI883760A0 (sv) 1988-08-12
FI883760A FI883760A (sv) 1989-02-16
FI90420B true FI90420B (sv) 1993-10-29
FI90420C FI90420C (sv) 1994-02-10

Family

ID=10622374

Family Applications (1)

Application Number Title Priority Date Filing Date
FI883760A FI90420C (sv) 1987-08-15 1988-08-12 Förfarande för framställning av terapeutiskt användbara tetrahydroisokinolinderivat

Country Status (13)

Country Link
US (1) US4965360A (sv)
EP (1) EP0308059B1 (sv)
JP (1) JP2800830B2 (sv)
AT (1) ATE80395T1 (sv)
CA (1) CA1332415C (sv)
DE (1) DE3874465T2 (sv)
DK (1) DK171299B1 (sv)
ES (1) ES2051856T3 (sv)
FI (1) FI90420C (sv)
GB (1) GB8719378D0 (sv)
GR (1) GR3005840T3 (sv)
IE (1) IE61749B1 (sv)
PT (1) PT88256B (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9711650D0 (en) * 1997-06-05 1997-07-30 Pfizer Ltd Compounds useful in therapy
GB0112061D0 (en) * 2001-05-18 2001-07-11 Pfizer Ltd Process for the production of quinazolines
GB0118752D0 (en) * 2001-08-01 2001-09-26 Pfizer Ltd Process for the production of quinazolines
KR100863692B1 (ko) * 2006-12-08 2008-10-15 울산대학교 산학협력단 퇴행성질환 및 염증질환에 대한 예방치료 효과를 갖는7-하이드록시-6-메톡시-1,2,3,4-테트라하이드로이소퀴놀린유도체
KR100870576B1 (ko) * 2008-08-27 2008-11-27 울산대학교 산학협력단 퇴행성질환 및 염증질환에 대한 예방치료 효과를 갖는 7-하이드록시-6-메톡시-1,2,3,4-테트라하이드로이소퀴놀린 유도체

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3855228A (en) * 1972-08-21 1974-12-17 Sterling Drug Inc 3,4-dihydro-1-or 3-(polyfluoroalkyl)-2(1h)-isoquinolinecarboxamidoximes
US4656174A (en) * 1982-07-24 1987-04-07 Pfizer Inc. Quinoline therapeutic agents

Also Published As

Publication number Publication date
IE882474L (en) 1989-02-15
IE61749B1 (en) 1994-11-30
PT88256A (pt) 1989-06-30
DE3874465T2 (de) 1993-02-25
EP0308059B1 (en) 1992-09-09
DK452088A (da) 1989-02-16
DK171299B1 (da) 1996-08-26
PT88256B (pt) 1995-03-01
FI883760A0 (sv) 1988-08-12
JP2800830B2 (ja) 1998-09-21
DK452088D0 (da) 1988-08-12
DE3874465D1 (de) 1992-10-15
GB8719378D0 (en) 1987-09-23
FI90420C (sv) 1994-02-10
ES2051856T3 (es) 1994-07-01
EP0308059A1 (en) 1989-03-22
US4965360A (en) 1990-10-23
CA1332415C (en) 1994-10-11
JPH01110680A (ja) 1989-04-27
FI883760A (sv) 1989-02-16
ATE80395T1 (de) 1992-09-15
GR3005840T3 (sv) 1993-06-07

Similar Documents

Publication Publication Date Title
JP2716146B2 (ja) 縮合インドール誘導体およびその製造方法
CA2284802C (en) Substituted isoquinolines as ultra short acting neuromuscular blockers
JPS63280078A (ja) ヘテロニ環式キノロン誘導体
CA2550726A1 (en) Methods of preparing aripiprazole crystalline forms
JPH0219112B2 (sv)
US5006537A (en) 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones
EP0040401A1 (en) Triazoloquinoxalin-4-ones and such oxaline-4-thiones
KR19990063850A (ko) Nmda 길항제로서의 테트라히드로퀴놀린
FI90420B (sv) Förfarande för framställning av terapeutiskt användbara tetrahydroisokinolinderivat
EP0145010A2 (en) Carbostyril derivatives
CA1250582A (en) Tetrahydrocorynantheine derivatives and process for their preparation
PT85688B (pt) Processo para a preparacao de novos naftilderivados, e de composicoes farmaceuticas que os contenham
EP0273401B1 (en) Isoindolin-1-one derivative and antiarrhythmic agent
US4882337A (en) Tetrahydroisoquinoline antiarrhythmic agents
KR100453981B1 (ko) 아미노피롤린 화합물, 이의 제조 방법 및 이를 함유하는약제 조성물
KR930003611B1 (ko) 퀴놀론 카복실산 유도체의 제조방법
US4143143A (en) Substituted imidazo[5,1-a]isoquinolines
JPH02124885A (ja) イミダゾール抗不整脈剤
US20030097000A1 (en) 2-Phenyl-quinoline derivatives, preparation method and therapeutic use thereof
EP0278265B1 (en) 1- [(4-Morpholinyl) alkyl] -1H-indoles useful as analgesics and preparation thereof
JPS6058919B2 (ja) フタリジル−イソキノリン誘導体、その製造法及びそれを含有する医薬
JP2966893B2 (ja) 新規キノロン―３―カルバルデヒド誘導体およびその塩
JP2003502328A (ja) 心不整脈の処置に有用な新規ビスピジン化合物
EP0347733A1 (en) Optically active hydantoin derivatives
CN118290396A (zh) 用于预防和/或治疗神经退行性疾病的化合物

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: PFIZER LIMITED